• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - CW; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - CW; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMC3228C150TJ
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Cardiac Arrest (1762); Death (1802)
Event Date 05/29/2019
Event Type  Death  
Manufacturer Narrative
(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
A valiant captivia stent graft was implanted in a patient for the endovascular treatment of an unknown sized thoracic aortic aneurysm.A non-mdt stent graft was also implanted during the procedure.It was reported during the index procedure after the valiant navion was successfully implanted the non-mdt stent graft was placed at the target position.It was reported that just before implantation, bradycardia and cardiac arrest occurred.Angiography was performed and confirmed the presence of aortic regurgitation.Percutaneous cardiopulmonary support (pcps) was carried out.The symptoms recovered temporarily by using cardiac massage and a defibrillator and pcps was stopped.Angiography was performed again and the non-mdt stent graft implanted successfully.Angiography was performed again and confirmed that the aortic regurgitation persisted, and cardiac arrest then re-occurred.Pcps was restarted and intra-aortic balloon pumping (iabp) was also used to assist with circulation.The patient was transferred to the intensive care unit and was reported to have expired three days post the index procedure.As per the physician, the patient has a medical history of heart failure and poor heart condition.It was unable to be concluded at what point the aortic regurgitation occurred.It was considered, however, that there was the possibility the guide wire used during the procedure may have made contact with and damaged the aortic valve during the implantation of the non-mdt stent graft.No additional clinical sequalae were reported and the patient is expired.
 
Manufacturer Narrative
Additional information: temporary pacing was also started when pcps was first commenced.It was confirmed that there was no direct cause of death reported as no autopsy was performed.Pcps was used for cardiac arrest and iabp was used for assisted circulation.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - CW
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
091708096
MDR Report Key9685746
MDR Text Key178302560
Report Number9612164-2020-00625
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/10/2021
Device Model NumberVAMC3228C150TJ
Device Catalogue NumberVAMC3228C150TJ
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/15/2020
Initial Date FDA Received02/10/2020
Supplement Dates Manufacturer Received02/20/2020
Supplement Dates FDA Received02/28/2020
Date Device Manufactured02/11/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-